Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
The caudate nucleus from examples of Alzheimer's disease (mean age 68, range 51-77 yr) had a mean wet weight and total protein content that were significantly lower than control. Biochemical markers of various specific nerve cells were determined. These are thought to reflect intrinsic choliner...
Asıl Yazarlar: | Pearce, B, Palmer, A, Bowen, D, Wilcock, G, Esiri, M, Davison, A |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
1984
|
Benzer Materyaller
-
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
Yazar:: Bowen, D, ve diğerleri
Baskı/Yayın Bilgisi: (1983) -
The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.
Yazar:: Wilcock, G, ve diğerleri
Baskı/Yayın Bilgisi: (1983) -
Reduced GLP-1R availability in the caudate nucleus with Alzheimer’s disease
Yazar:: Emma Barrett, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01) -
TRPV4 mRNA is elevated in the caudate nucleus with NPH but not in Alzheimer’s disease
Yazar:: Hunter White, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01) -
Interpretive monitoring in the caudate nucleus
Yazar:: Marianna Yanike, ve diğerleri
Baskı/Yayın Bilgisi: (2014-11-01)